Detailed report on 2014/15 influenza virus characteristics, and estimates on influenza virus vaccine effectiveness from Austria's sentinel physician surveillance network

PLoS ONE

Volumn 11, Issue 3, 2016, Pages

  Redlberger Fritz, Monika ^a   Kundi, Michael ^a   Popow Kraupp, Theresia ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE;

ADOLESCENT; ADULT; AGED; ARTICLE; AUSTRIA; CASE CONTROL STUDY; CHILD; DRUG EFFICACY; FEMALE; HUMAN; INFLUENZA; INFLUENZA A VIRUS (H1N1); INFLUENZA A VIRUS (H3N2); INFLUENZA B VIRUS; INFLUENZA VACCINATION; INFLUENZA VIRUS; MALE; NONHUMAN; PRIMARY MEDICAL CARE; SENTINEL SURVEILLANCE; VIRUS STRAIN; CLINICAL TRIAL; PRIMARY HEALTH CARE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; AUSTRIA; FEMALE; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; PRIMARY HEALTH CARE; SENTINEL SURVEILLANCE;

EID: 84962259046     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0149916     Document Type: Article

References (36)

1. Stucker KM, Schobel SA, Olsen R.J., Hodges HL, Lin X, Halpin RA et al. Haemagglutinin mutations and glycosylation changes shaped the 2012/13 influenza A(H3N2) epidemic, Houston, Texas. Euro Surveill. 2015; 20(18). doi:21122 [pii].
2. (WHO) WHO. Influenza (Seasonal) In: Fact sheet No 211 2014. http://www.who.int/mediacentre/factsheets/fs211/en/.
3. Skowronski DM, Chambers C, Sabaiduc S, De Serres G, Winter AL, Dickinson JA et al. Integrated Sentinel Surveillance Linking Genetic, Antigenic, and Epidemiologic Monitoring of Influenza Vaccine-Virus Relatedness and Effectiveness During the 2013-2014 Influenza Season. J Infect Dis. 2015. [pii] doi: 10.1093/infdis/jiv177
4. Heikkinen T, Heinonen S. Effectiveness and safety of influenza vaccination in children: European perspective. Vaccine. 2011; 29(43):7529-34. doi: 10.1016/j.vaccine.2011.08.011 S0264-410X(11)01220-5 [pii]. PMID: 21820481
5. Skowronski DM, Janjua NZ, De Serres G, Sabaiduc S, Eshaghi A, Dickinson JA et al. Low2012-13 influenza vaccine effectiveness associated with mutation in the egg-adapted H3N2 vaccine strain not antigenic drift in circulating viruses. PLoS One. 2014; 9(3):e92153. doi: 10.1371/journal.pone.0092153 PONE-D-13-54409 [pii]. PMID: 24667168
6. Skowronski DM, De Serres G, Dickinson J, Petric M., Mak A, Fonseca K et al. Component-specific effectiveness of trivalent influenza vaccine as monitored through a sentinel surveillance network in Canada, 2006-2007. J Infect Dis. 2009; 199(2):168-79. doi: 10.1086/595862 PMID: 19086914
7. Janjua NZ, Skowronski DM, De Serres G, Dickinson J, Crowcroft NS, Taylor M et al. Estimates of influenza vaccine effectiveness for 2007-2008 from Canada's sentinel surveillance system: cross-protection against major and minor variants. J Infect Dis. 2012; 205(12):1858-68. doi: 10.1093/infdis/jis283 [pii]. PMID: 22492921
8. Osterholm MT, Kelley NS, Sommer A, Belongia EA. Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis. Lancet Infect Dis. 2012; 12(1):36-44. doi: 10.1016/S1473-3099(11)70295-X [pii]. PMID: 22032844
9. Kunze U, Bohm G, Groman E. Influenza vaccination in Austria from 1982 to 2011: a country resistant to influenza prevention and control. Vaccine. 2013; 31(44):5099-103. doi: 10.1016/j.vaccine.2013.08. 050S0264-410X(13)01162-6 [pii]. PMID: 24012564
10. Skowronski DM, Gilbert M, Tweed S.A., Petric M., Li Y, Mak A, et al. Effectiveness of vaccine against medical consultation due to laboratory-confirmed influenza: results from a sentinel physician pilot project in british columbie, 2004-2005. CanComm Dis Rep. 2005; 31(18):181-90.
11. Skowronski DM, Masaro C, Kwindt TL, Mak A, Petric M, Li Y et al. Estimating vaccine effectiveness against laboratory-confirmed influenza using a sentinel physician network: results from the 2005-2006 season of dual A and B vaccine mismatch in Canada. Vaccine. 2007; 25(15):2842-51. doi: S0264-410X(06)01105-4 [pii] doi: 10.1016/j.vaccine.2006.10.002 PMID: 17081662
12. De Serres G., Skowronski DM, Wu XW, Ambrose CS. The test-negative design: validity, accuracy and precision of vaccine efficacy estimates compared to the gold standard of randomised placebo-controlled clinical trials. Euro Surveill. 2013; 18(37). doi:20585 [pii].
13. Kissling E, Valenciano M, Buchholz U, Larrauri A, Cohen JM, Nunes B et al. Influenza vaccine effectiveness estimates in Europe in a season with three influenza type/subtypes circulating: the I-MOVE multicentre case-control study, influenza season 2012/13. Euro Surveill. 2014; 19(6). doi:20701 [pii].
14. Kissling E, Valenciano M, Cohen JM, Oroszi B, Barret AS, Rizzo C et al. I-MOVE multi-centre case control study 2010-11: overall and stratified estimates of influenza vaccine effectiveness in Europe. PLoS One. 2011; 6(11):e27622. doi: 10.1371/journal.pone.0027622 PONE-D-11-18077 [pii]. PMID: 22110695
15. Kissling E, Valenciano M, Larrauri A, Oroszi B, Cohen JM, Nunes B et al. Low and decreasing vaccine effectiveness against influenza A(H3) in 2011/12 among vaccination target groups in Europe: results from the I-MOVE multicentre case-control study. Euro Surveill. 2013; 18(5). doi:20390 [pii].
16. Valenciano M, Kissling E. Early estimates of seasonal influenza vaccine effectiveness in Europe: results from the I-MOVE multicentre case-control study, 2012/13. Euro Surveill. 2013; 18(7):3. doi:20400 [pii]. PMID: 23449183
17. Valenciano M, Kissling E, Reuss A., Jimenez-Jorge S, Horvath JK, Donnell JM et al. The European I-MOVE Multicentre 2013-2014 Case-Control Study. Homogeneous moderate influenza vaccine effectiveness against A(H1N1)pdm09 and heterogenous results by country against A(H3N2). Vaccine. 2015; 33(24):2813-22. doi: 10.1016/j.vaccine.2015.04.012 S0264-410X(15)00465-X [pii]. PMID: 25936723
18. ECDC. ECDC Influenza case definition. http://ecdceuropaeu/en/activities/surveillance/EISN/surveillance/Pages/influenzacasedefinitionsaspx.
19. (ECDC) ECfDPaC. Influenza virus characterisation. In: Surveillance Report. 2015. http://ecdc.europa.eu/en/publications/publications/influenza-virus-characterisation-april-2015.pdf.
20. Redlberger M, Aberle SW, Heinz F.X., Popow-Kraupp T. Dynamics of antigenic and genetic changes in the hemagglutinins of influenza A/H3N2 viruses of three consecutive seasons (2002/2003 to 2004/2005) in Austria. Vaccine. 2007; 25(32):6061-9. doi: S0264-410X(07)00569-5 [pii] doi: 10.1016/j.vaccine.2007.05.045 PMID: 17601639
21. Nicholson KG, Wood JM, Zambon M. Influenza. Lancet. 2003; 362(9397):1733-45. doi: S0140-6736(03)14854-4 [pii] doi: 10.1016/S0140-6736(03)14854-4 PMID: 14643124
22. Morokutti A, Redlberger-Fritz M, Nakowitsch S., Krenn BM, Wressnigg N, Jungbauer A et al. Validation of the modified hemagglutination inhibition assay (mHAI), a robust and sensitive serological test for analysis of influenza virus-specific immune response. J Clin Virol. 2013; 56(4):323-30. doi: 10.1016/j.jcv.2012.12.002 S1386-6532(12)00442-8 [pii]. PMID: 23375739
23. Jackson ML, Nelson JC The test-negative design for estimating influenza vaccine effectiveness. Vaccine. 2013; 31(17):2165-8. doi: 10.1016/j.vaccine.2013.02.053 S0264-410X(13)00242-9 [pii]. PMID: 23499601
24. Jackson ML, Rothman KJ Effects of imperfect test sensitivity and specificity on observational studies of influenza vaccine effectiveness. Vaccine. 2015; 33(11):1313-6. doi: 10.1016/j.vaccine.2015.01.069 S0264-410X(15)00126-7 [pii]. PMID: 25659280
25. Valenciano M, Kissling E, Ciancio BC, Moren A. Study designs for timely estimation of influenza vaccine effectiveness using European sentinel practitioner networks. Vaccine. 2010; 28(46):7381-8. doi: 10.1016/j.vaccine.2010.09.010 S0264-410X(10)01318-6 [pii]. PMID: 20851086
26. Skowronski DM, Chambers C, Sabaiduc S, De Serres G, Dickinson JA, Winter AL et al. Interim estimates of 2014/15 vaccine effectiveness against influenza A(H3N2) from Canada's Sentinel Physician Surveillance Network, January 2015. Euro Surveill. 2015; 20(4). doi:21022 [pii].
27. Fonville JM, Wilks SH, James S.L., Fox A., Ventresca M, Aban M et al. Antibody landscapes after influenza virus infection or vaccination. Science. 2014; 346(6212):996-1000. doi: 10.1126/science.1256427 346/6212/996 [pii]. PMID: 25414313
28. Smith DJ, Forrest S, Ackley D.H., Perelson AS. Variable efficacy of repeated annual influenza vaccination. Proc Natl Acad Sci USA. 1999; 96(24):14001-6. PMID: 10570188
29. Pebody RG, Warburton F, Ellis J., Andrews N, Thompson C, von Wissmann B et al. Low effectiveness of seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2014/15 mid-season results. Euro Surveill. 2015; 20(5):21025. doi:21025 [pii]. PMID: 25677050
30. Pebody R, Warburton F, Andrews N., Ellis J, von Wissmann B, Robertson C et al. Effectiveness of seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2014/15 end of season results. Euro Surveill. 2015; 20(36). doi:10.2807/1560-7917.ES.2015.20.36.30013 30013 [pii].
31. Petrie JG, Ohmit SE, Johnson E, Truscon R, Monto AS. Persistence of Antibodies to Influenza Hemagglutinin and Neuraminidase Following One or Two Years of Influenza Vaccination. J Infect Dis. 2015; 212(12):1914-22. doi: 10.1093/infdis/jiv313 [pii]. PMID: 26014800
32. McLean HQ, Thompson MG, Sundaram ME, Meece JK, McClure DL, Friedrich TC et al. Impact of repeated vaccination on vaccine effectiveness against influenza A(H3N2) and B during 8 seasons. Clin Infect Dis. 2014; 59(10):1375-85. doi: 10.1093/cid/ciu680 [pii]. PMID: 25270645
33. Gilca R, Skowronski DM, Douville-Fradet M, Amini R., Boulianne N, Rouleau I et al. Mid-Season Estimates of Influenza Vaccine Effectiveness against Influenza A(H3N2) Hospitalization in the Elderly in Quebec, Canada, January 2015. PLoS One. 2015; 10(7):e0132195. doi: 10.1371/journal.pone.0132195 PONE-D-15-08873 [pii]. PMID: 26200655
34. Monto AS, Koopman JS, Longini IM Jr. Tecumseh study of illness. XIII. Influenza infection and disease, 1976-1981. Am J Epidemiol. 1985; 121(6):811-22. PMID: 4014174
35. Hancock K, Veguilla V, Lu X, Zhong W, Butler EN, Sun H et al. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med. 2009; 361(20):1945-52. doi: 10.1056/NEJMoa0906453 [pii]. PMID: 19745214
36. Savage RD, Winter AL, Rosella L.C., Olsha R., Gubbay JB, Skowronski DM et al. Strengths and limitations of assessing influenza vaccine effectiveness using routinely collected, passive surveillance data in Ontario, Canada, 2007 to 2012: balancing efficiency versus quality. Euro Surveill. 2015; 20(16). doi:21100 [pii].